Department of Urology, Bichat Claude Bernard Hospital, Paris Diderot University Medical School, Paris, France.
BJU Int. 2012 Dec;110(11 Pt B):E438-42. doi: 10.1111/j.1464-410X.2012.10964.x. Epub 2012 Feb 28.
What's known on the subject? and What does the study add? Stone density on non-contrast computed tomography (NCCT) is reported to be a prognosis factor for extracorporeal shockwave lithotripsy (ESWL). In this prospective study, we determined that a 970 HU threshold of stone density is a very specific and sensitive threshold beyond which the likelihood to be rendered stone free is poor. Thus, NCCT evaluation of stone density before ESWL may useful to identify which patients should be offered alternative treatment to optimise their outcome.
• To evaluate the usefulness of measuring urinary calculi attenuation values by non-contrast computed tomography (NCCT) for predicting the outcome of treatment by extracorporeal shockwave lithotripsy (ESWL).
• We prospectively evaluated 50 patients with urinary calculi of 5-22 mm undergoing ESWL. • All patients had NCCT at 120 kV and 100 mA on a spiral CT scanner. Patient age, sex, body mass index, stone laterality, stone size, stone attenuation values (Hounsfield units [HU]), stone location, and presence of JJ stent were studied as potential predictors. • The outcome was evaluated 4 weeks after the ESWL session by NCCT. • ESWL success was defined as patients being stone-free (SF) or with remaining stone fragments of <4 mm, which were considered as clinically insignificant residual fragments (CIRF).
• Our survey concluded that 26 patients (52%) were SF, 12 (24%) had CIRF and 12 (24%) had residual fragment on NCCT after a one ESWL treatment. • Stones of patients who became SF or had CIRF had a lower density compared with stones in patients with residual fragments [mean (sd) 715 (260) vs 1196 (171) HU, P < 0.001]. • The Youden Index showed that a stone density of 970 HU represented the most sensitive (100%) and specific (81%) point on the receiver-operating characteristic curve. • The stone-free rate for stones of <970 HU was 96% vs 38% for stones of ≥ 970 HU (P < 0.001). A linear relationship between the calculus density and the success rate of ESWL was identified.
• The use of NCCT to determine the attenuation values of urinary calculi before ESWL helps to predict treatment outcome, and, consequently, could be helpful in planning alternative treatment for patients with a likelihood of a poor outcome from ESWL.
• 评估非增强 CT(NCCT)测量尿结石衰减值对预测体外冲击波碎石术(ESWL)治疗结果的作用。
• 我们前瞻性评估了 50 例 5-22mm 尿结石患者,进行 ESWL。• 所有患者均在螺旋 CT 扫描仪上以 120kV 和 100mA 行 NCCT。研究了患者年龄、性别、体重指数、结石侧位、结石大小、结石衰减值(Hounsfield 单位[HU])、结石位置以及 JJ 支架的存在情况作为潜在的预测因素。• 通过 NCCT 在 ESWL 治疗 4 周后评估治疗结果。• ESWL 成功定义为患者无结石(SF)或有<4mm 的残余结石碎片,认为是临床无意义的残余碎片(CIRF)。
• 我们的调查结果表明,26 例(52%)患者为 SF,12 例(24%)为 CIRF,12 例(24%)在一次 ESWL 治疗后 NCCT 上有残余结石碎片。• SF 或 CIRF 患者的结石密度明显低于有残余碎片患者的结石密度[(均数(标准差):715(260)HU 比 1196(171)HU,P<0.001]。• 约登指数表明,结石密度 970HU 是最敏感(100%)和最特异(81%)的受试者工作特征曲线切点。• 结石密度<970HU 的结石无石率为 96%,而结石密度≥970HU 的结石无石率为 38%(P<0.001)。确定了结石密度与 ESWL 成功率之间的线性关系。
• 在 ESWL 前使用 NCCT 确定尿结石的衰减值有助于预测治疗结果,从而有助于为 ESWL 治疗效果不佳的患者制定替代治疗方案。